GI
ABBV icon

GAMMA Investing’s AbbVie ABBV Stock Holding History

GAMMA Investing’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Buy
68,002
+5,149
+8% +$1.11M 0.64% 23
2026
Q1 		$13.7M Buy
62,853
+2,118
+3% +$470K 0.64% 21
2025
Q4 		$13.9M Buy
60,735
+3,576
+6% +$815K 0.7% 19
2025
Q3 		$13.2M Buy
57,159
+4,633
+9% +$943K 0.73% 17
2025
Q2 		$9.75M Buy
52,526
+3,678
+8% +$684K 0.62% 21
2025
Q1 		$10.2M Buy
48,848
+9,395
+24% +$1.83M 0.77% 17
2024
Q4 		$7.01M Buy
39,453
+3,439
+10% +$632K 0.6% 23
2024
Q3 		$7.11M Buy
36,014
+8,014
+29% +$1.5M 0.71% 19
2024
Q2 		$4.8M Buy
28,000
+8,640
+45% +$1.43M 0.65% 20
2024
Q1 		$3.53M Buy
19,360
+3,083
+19% +$531K 0.72% 19
2023
Q4 		$2.68M Buy
+16,277
New +$2.37M 0.72% 20

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

GAMMA Investing's ABBV Position: Q2 2026 in Review

GAMMA Investing increased its AbbVie (ABBV) stake by 8.2% in Q2 2026, buying an estimated $1.11M and bringing the position to 68,002 shares worth $17.1M. The position accounts for 0.64% of the portfolio, ranked #23.

GAMMA Investing first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • GAMMA Investing held 68,002 shares of AbbVie worth $17.1M as of Q2 2026.
  • GAMMA Investing bought 5,149 AbbVie shares in Q2 2026, an estimated $1.11M.
  • AbbVie made up 0.64% of GAMMA Investing's portfolio in Q2 2026, its #23 holding.
  • GAMMA Investing first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.